
Douglas M. Lankler is Executive Vice President and Chief Legal Officer of Pfizer Inc. Doug reports to the Chairman and Chief Executive Officer. He has been with Pfizer since 1999, has been a member of Pfizer’s management team since 2009, and has led the legal division since 2013.
As Chief Legal Officer, Doug supervises all aspects of Pfizer’s legal division. He has responsibility for legal aspects of corporate governance, commercial, compliance, litigation, business development, research, labor, and intellectual property issues.
Doug is a former Assistant United States Attorney for the Southern District of New York, where he prosecuted corporate and organized crime, white collar fraud, and terrorism. In 1999, he received the Attorney General’s Distinguished Service Award.
Doug is a graduate of the State University of New York at Albany and Cornell Law School.

Dan Kracov is chair of Arnold & Porter’s Global Life Sciences Industry group, which was honored by Law360 in 2020 and 2022 as a "Life Sciences Practice Group of the Year." For decades, he has been one of the foremost Food and Drug Administration lawyers in the country, and his expertise in critical regulatory matters has been widely recognized by Chambers, the Legal Times, Best Lawyers in America, and many other publications. Most recently, Dan received the Food and Drug Law Institute (FDLI) Distinguished Service and Leadership Award. A particular focus of his practice is assisting pharmaceutical, biotechnology, medical device, and diagnostic companies, including start-up companies, trade associations, and large manufacturers, negotiate challenges relating to the development, approval, and marketing of FDA-regulated products.
In addition to day-to-day counseling on regulatory and compliance strategies and concerns, Dan regularly handles product and compliance-related government and internal investigations, the development of global corporate compliance programs, and due diligence in financings, mergers, and acquisitions. He also has a widely recognized experience in biomedical public policy matters, including Congressional investigations and advising on FDA-related legislation.
at
Online Zoom Conference
About
With any questions on this event or membership, please email: kate@osherpartners.org.
Join us for an intimate Zoom Roundtable with Doug Lankler, Chief Legal Officer at Pfizer. This session will be an opportunity to connect with a select, intimate group of young rising philanthropists in our network as we convene on April 1st at 6:00pm-7:00pm.
Douglas M. Lankler is the Executive Vice President and Chief Legal Officer at Pfizer, overseeing legal affairs since 2013. He joined Pfizer in 1999 after serving as an Assistant U.S. Attorney for the Southern District of New York, where he prosecuted corporate and organized crime. Lankler holds a bachelor's from SUNY Albany and a J.D. from Cornell Law School.
Pfizer Inc. is a global pharmaceutical company headquartered in New York City. Founded in 1849, it is known for developing innovative medicines and vaccines across various therapeutic areas, including oncology, immunology, and infectious diseases. Pfizer played a key role in developing the COVID-19 vaccine in partnership with BioNTech. The company focuses on advancing healthcare through research, biotechnology, and patient-centered solutions.
Attendee Policy
Osher Business Programs are open to professionals from the ages of 26-40. If you are interested in attending, please apply by clicking the "register" button. A member of our team will review your information and get back to you shortly. If you are over age 40 and do not qualify for this session, we will be happy to provide further information on involvement opportunities for which you do qualify. Non-members of Osher are welcome to join one event to experience our group. After your first event we ask that you apply to become a member if you wish to continue being involved in our community.
Non-Solicitation Policy
Osher has a non-solicitation policy covering all of our conferences and events. In order to provide a distraction-free environment for our mentors, sponsors, attendees, and employees, we do not allow solicitation at our events by attendees or unauthorized parties without the express written permission or consent from Osher.
Partial Guest List








